Includes hospital compounding pharmacies and specialty API distributors
Most telehealth companies use 503A pharmacies to fill their personalized compounded doses, said Rosalie Hoyle, a research scientist at health consultant Avalere, adding the exclusion from the 503B list may not operationally impact current compounding of GLP-1 drugs
Studies show that 60% of people taking orlistat lost at least 5% of their body weight after 6 months, and 41% of these people went onto lose at least 10% after 12 months
partner to bring ecnoglutide to American patients, and is pursuing partnerships in Latin America and the Middle East
Participants were randomly assigned to different treatment groups, allowing researchers to evaluate a range of starting doses, dose-escalation approaches, and maintenance doses
But even as a standalone, cagrilintide provides meaningful weight loss through GLP-1-independent mechanisms